Osaic Holdings
AVBP icon

Osaic Holdings’s ArriVent BioPharma AVBP Stock Holding History

Osaic Holdings’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.4K Hold
702
– – ﹤0.01% 6021
2026
Q1 		$16.2K Buy
702
+106
+18% +$2.39K ﹤0.01% 5997
2025
Q4 		$12K Buy
596
+118
+25% +$2.46K ﹤0.01% 6225
2025
Q3 		$8.82K Buy
478
+309
+183% +$6.07K ﹤0.01% 6443
2025
Q2 		$3.38K Buy
+169
New +$3.51K ﹤0.01% 6746
2025
Q1 		– Sell
-17
Closed -$453 – 7743
2024
Q4 		$453 Buy
+17
New +$488 ﹤0.01% 7039

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Osaic Holdings's AVBP Position: Q2 2026 in Review

Osaic Holdings held its ArriVent BioPharma (AVBP) position steady in Q2 2026 at 702 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6021.

Osaic Holdings first reported a position in AVBP in Q4 2024 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Osaic Holdings held 702 shares of ArriVent BioPharma worth $24.4K as of Q2 2026.
  • Osaic Holdings left its ArriVent BioPharma share count unchanged in Q2 2026.
  • ArriVent BioPharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6021 holding.
  • Osaic Holdings first reported a position in ArriVent BioPharma in Q4 2024 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.